位置:首页 > 蛋白库 > DART_THEA5
DART_THEA5
ID   DART_THEA5              Reviewed;         222 AA.
AC   P0DV56;
DT   03-AUG-2022, integrated into UniProtKB/Swiss-Prot.
DT   03-AUG-2022, sequence version 1.
DT   03-AUG-2022, entry version 1.
DE   RecName: Full=DNA ADP-ribosyl transferase {ECO:0000303|PubMed:27939941};
DE            Short=DarT {ECO:0000303|PubMed:27939941};
DE            EC=2.4.2.- {ECO:0000269|PubMed:27939941, ECO:0000269|PubMed:34408320};
DE   AltName: Full=Toxin DarT {ECO:0000303|PubMed:27939941};
GN   Name=darT {ECO:0000305}; ORFNames=TO73_1568 {ECO:0000312|EMBL:ALJ91409.1};
OS   Thermus aquaticus (strain ATCC BAA-2747 / Y51MC23).
OC   Bacteria; Deinococcus-Thermus; Deinococci; Thermales; Thermaceae; Thermus.
OX   NCBI_TaxID=498848;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=BAA-2747 / Y51MC23;
RX   PubMed=26465632; DOI=10.1371/journal.pone.0138674;
RA   Brumm P.J., Monsma S., Keough B., Jasinovica S., Ferguson E.,
RA   Schoenfeld T., Lodes M., Mead D.A.;
RT   "Complete Genome Sequence of Thermus aquaticus Y51MC23.";
RL   PLoS ONE 10:e0138674-e0138674(2015).
RN   [2]
RP   FUNCTION AS A TOXIN, FUNCTION AS AN ADP-RIBOSYL TRANSFERASE, SUBSTRATE
RP   SPECIFICITY, CATALYTIC ACTIVITY, EXPRESSION IN E.COLI, SUBUNIT, PROBABLE
RP   ACTIVE SITE, AND MUTAGENESIS OF GLU-160.
RX   PubMed=27939941; DOI=10.1016/j.molcel.2016.11.014;
RA   Jankevicius G., Ariza A., Ahel M., Ahel I.;
RT   "The Toxin-Antitoxin System DarTG Catalyzes Reversible ADP-Ribosylation of
RT   DNA.";
RL   Mol. Cell 64:1109-1116(2016).
RN   [3]
RP   FUNCTION AS A TOXIN, FUNCTION AS AN ADP-RIBOSYL TRANSFERASE, CATALYTIC
RP   ACTIVITY, POSSIBLE REACTION MECHANISM, ACTIVE SITE, EXPRESSION IN E.COLI,
RP   AND MUTAGENESIS OF TYR-47; HIS-53; ARG-54; HIS-68; TYR-74; ARG-78; MET-81;
RP   TYR-83; HIS-122; ARG-154; GLN-158 AND GLU-160.
RX   PubMed=34408320; DOI=10.1038/s41586-021-03825-4;
RA   Schuller M., Butler R.E., Ariza A., Tromans-Coia C., Jankevicius G.,
RA   Claridge T.D.W., Kendall S.L., Goh S., Stewart G.R., Ahel I.;
RT   "Molecular basis for DarT ADP-ribosylation of a DNA base.";
RL   Nature 596:597-602(2021).
CC   -!- FUNCTION: Toxic component of a hybrid type II/IV toxin-antitoxin (TA)
CC       system. Its toxic effect is neutralized by cognate antitoxin DarG. ADP-
CC       ribosylates ssDNA on the second thymidine of the consensus sequence 5'-
CC       TNTC-3'; the protein does not auto-modify. Has no activity on dsDNA in
CC       vitro. This leads to a decrease in DNA replication. Upon expression in
CC       E.coli inhibits cell growth, colony formation and induces the SOS
CC       response. Expression leads to bacteriostasis; however if cells grow
CC       over an hour in the presence of toxin, growth is no longer restored on
CC       antitoxin-inducing plates (PubMed:27939941). In E.coli ADP-ribosylates
CC       genomic DNA (gDNA), which induces RecA expression (a marker for DNA
CC       damage) (PubMed:34408320). {ECO:0000269|PubMed:27939941,
CC       ECO:0000269|PubMed:34408320}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a thymidine in DNA + NAD(+) = an N-(ADP-alpha-D-ribosyl)-
CC         thymidine in DNA + H(+) + nicotinamide; Xref=Rhea:RHEA:71651,
CC         Rhea:RHEA-COMP:13556, Rhea:RHEA-COMP:18051, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17154, ChEBI:CHEBI:57540, ChEBI:CHEBI:137386,
CC         ChEBI:CHEBI:191199;
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71652;
CC         Evidence={ECO:0000269|PubMed:27939941, ECO:0000269|PubMed:34408320};
CC   -!- SUBUNIT: Probably forms a complex with cognate antitoxin DarG; this
CC       complex might decrease ADP-ribosylation activity of DarT.
CC       {ECO:0000305|PubMed:27939941}.
CC   -!- DOMAIN: The NAD(+)-binding element stabilizes the ADP-ribosylating
CC       turn-turn (ARTT) loop which confers substrate specificity; both domains
CC       contribute to ssDNA-binding. {ECO:0000250|UniProtKB:A0A0B0SG80}.
CC   -!- SIMILARITY: Belongs to the DarT ADP-ribosyltransferase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=ALJ91409.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP010822; ALJ91409.1; ALT_INIT; Genomic_DNA.
PE   1: Evidence at protein level;
KW   DNA-binding; Glycosyltransferase; Nucleotidyltransferase;
KW   Toxin-antitoxin system; Transferase.
FT   CHAIN           1..222
FT                   /note="DNA ADP-ribosyl transferase"
FT                   /id="PRO_0000456051"
FT   DOMAIN          15..209
FT                   /note="DarT"
FT                   /evidence="ECO:0000255"
FT   DNA_BIND        47..53
FT                   /evidence="ECO:0000250|UniProtKB:A0A0B0SG80"
FT   DNA_BIND        78..83
FT                   /evidence="ECO:0000250|UniProtKB:A0A0B0SG80"
FT   DNA_BIND        148..151
FT                   /evidence="ECO:0000250|UniProtKB:A0A0B0SG80"
FT   DNA_BIND        154..158
FT                   /evidence="ECO:0000250|UniProtKB:A0A0B0SG80"
FT   REGION          38..56
FT                   /note="NAD(+)-binding element"
FT                   /evidence="ECO:0000250|UniProtKB:A0A0B0SG80"
FT   REGION          119..160
FT                   /note="ADP-ribosylating turn-turn loop"
FT                   /evidence="ECO:0000250|UniProtKB:A0A0B0SG80"
FT   ACT_SITE        54
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305|PubMed:34408320"
FT   ACT_SITE        160
FT                   /evidence="ECO:0000305|PubMed:27939941,
FT                   ECO:0000305|PubMed:34408320"
FT   BINDING         16..18
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:A0A0B0SG80"
FT   BINDING         54
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:A0A0B0SG80"
FT   MUTAGEN         47
FT                   /note="Y->A: Still toxic in E.coli, decreased DNA ADP-
FT                   ribosylation activity."
FT                   /evidence="ECO:0000269|PubMed:34408320"
FT   MUTAGEN         53
FT                   /note="H->A: Still toxic in E.coli, decreased DNA ADP-
FT                   ribosylation activity."
FT                   /evidence="ECO:0000269|PubMed:34408320"
FT   MUTAGEN         54
FT                   /note="R->A,K: No longer toxic in E.coli, no longer ADP-
FT                   ribosylates ssDNA. No ADP-ribosylation of gDNA in vivo."
FT                   /evidence="ECO:0000269|PubMed:34408320"
FT   MUTAGEN         68
FT                   /note="H->A: Still toxic in E.coli, decreased ADP-
FT                   ribosylation."
FT                   /evidence="ECO:0000269|PubMed:34408320"
FT   MUTAGEN         74
FT                   /note="Y->A,S: Still toxic in E.coli, no longer ADP-
FT                   ribosylates ssDNA."
FT                   /evidence="ECO:0000269|PubMed:34408320"
FT   MUTAGEN         74
FT                   /note="Y->F: Still toxic in E.coli, decreased ADP-
FT                   ribosylation."
FT                   /evidence="ECO:0000269|PubMed:34408320"
FT   MUTAGEN         78
FT                   /note="R->A: Still toxic in E.coli, decreased DNA ADP-
FT                   ribosylation activity."
FT                   /evidence="ECO:0000269|PubMed:34408320"
FT   MUTAGEN         81
FT                   /note="M->A: Still toxic in E.coli, no longer ADP-
FT                   ribosylates ssDNA."
FT                   /evidence="ECO:0000269|PubMed:34408320"
FT   MUTAGEN         83
FT                   /note="Y->A: Still toxic in E.coli, decreased DNA ADP-
FT                   ribosylation activity."
FT                   /evidence="ECO:0000269|PubMed:34408320"
FT   MUTAGEN         122
FT                   /note="H->A: No longer toxic in E.coli, no longer ADP-
FT                   ribosylates ssDNA. No ADP-ribosylation of gDNA in vivo."
FT                   /evidence="ECO:0000269|PubMed:34408320"
FT   MUTAGEN         122
FT                   /note="H->N: Still toxic in E.coli, decreased ADP-
FT                   ribosylation."
FT                   /evidence="ECO:0000269|PubMed:34408320"
FT   MUTAGEN         154
FT                   /note="R->A: Still toxic in E.coli, decreased DNA ADP-
FT                   ribosylation activity."
FT                   /evidence="ECO:0000269|PubMed:34408320"
FT   MUTAGEN         154
FT                   /note="R->W: No longer toxic in E.coli, no longer ADP-
FT                   ribosylates ssDNA. No ADP-ribosylation of gDNA in vivo."
FT                   /evidence="ECO:0000269|PubMed:34408320"
FT   MUTAGEN         158
FT                   /note="Q->A: Still toxic in vivo, decreased DNA ADP-
FT                   ribosylation activity."
FT                   /evidence="ECO:0000269|PubMed:34408320"
FT   MUTAGEN         160
FT                   /note="E->A: No longer toxic when expressed in E.coli, no
FT                   longer ADP-ribosylates ssDNA, no effect on DNA replication.
FT                   No ADP-ribosylation of gDNA in vivo. Very low activity at
FT                   low DNA, high protein levels and after 24 hours."
FT                   /evidence="ECO:0000269|PubMed:27939941,
FT                   ECO:0000269|PubMed:34408320"
FT   MUTAGEN         160
FT                   /note="E->D,Q: No longer toxic in E.coli, no longer ADP-
FT                   ribosylates ssDNA."
FT                   /evidence="ECO:0000269|PubMed:34408320"
SQ   SEQUENCE   222 AA;  25702 MW;  BC5ED363012570E6 CRC64;
     MPQQGLAYPV PTLIYHITHL NNLQGILQRG GLLPYSQRPP TQQNVAYGHI QAHRAQVVVP
     VGPRGKLHDY VPFYFCPRSP MLYAIHTQQT DYQGDQRPIL HLVSSAQKVA EARIPFVFTD
     RHAAVQYVCF FHKLEHLKAL DWQAIQASYW ANVREKKQAE FLVKDFFPWE LVEEIGVIDK
     TIQAQVESIL AQFPDLHHPP VRVRRSWYYK KRLCSASCEA TF
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024